Trodelvy 180 mg lyophilized powder for injection Images
Generic Name: sacituzumab govitecan
This medication has been identified as Trodelvy 180 mg lyophilized powder for injection and is used for Breast Cancer. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.
Images of medication
Trodelvy
- Generic Name
- sacituzumab govitecan
- Strength
- 180 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 55135-0132
See also:
More about Trodelvy (sacituzumab govitecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.